Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Health Research Projects

McGill University

$92,441.00

Enhancement of biocompatibility of coronary stents by surface immobilization of fibronectin and controlled tailoring of protein-cell interactions

FY 2010-11

Summary
Coronary artery disease, characterized by a progressive narrowing and blocking of blood vessels, is the leading cause of death in developed countries and accounts for about one fifth of the deaths in Canada. Angioplasty, which is an interventional procedure used for reopening blocked arteries without major surgery, is a common and effective procedure to reestablish blood flow in the blocked arteries. In 80% of cases, a stent is placed in the vessel to keep it open following the balloon angioplasty procedure. Although the stents currently in use are excellent in providing clinical benefits, they have many serious disadvantages resulting from limited biocompatibility, leading to stent blockage and restenosis. This, in turn, leads to a decline in the quality of life of the patient, increased morbidity rate and increased health care costs. We propose to develop a more compatible coronary stent by modifying the surface of the most commonly used stainless steel stent with an irreversibly immobilized and structurally stable monolayer of the extracellular matrix protein, fibronectin (FN). By controlled engineering of physico-chemical properties of the surface, the immobilized FN will adopt the surface conformation most favorable for endothelial cell-material interactions. We hypothesize that the FN-modified stent will be more biocompatible then stents currently available on the market, which will result in a decreased restenosis rate, improved quality of life of the patient, and decreased health-care costs. We will use advanced techniques and approaches for nano-structuring of solid surfaces to engineer the stent surface at a nano/molecular level in order to achieve the desired surface bio-physico-chemical properties. We will use a wide range of experimental techniques to investigate these properties, and perform a detailed analysis of the interaction of vascular smooth muscle cells and endothelial cells with the FN-modified surface. Ultimately, we will test the effectiveness of the FN-stent in vivo using an animal model.
Program
Collaborative Health Research Projects
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
350990-2008
Name nom
Omanovic, Sasha
Department département
Chemical Engineering
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2008
Award amount
92441
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
3
Nb partie
3
Application title
Enhancement of biocompatibility of coronary stents by surface immobilization of fibronectin and controlled tailoring of protein-cell interactions
Keyword
NSERC
Application summary
Coronary artery disease, characterized by a progressive narrowing and blocking of blood vessels, is the leading cause of death in developed countries and accounts for about one fifth of the deaths in Canada. Angioplasty, which is an interventional procedure used for reopening blocked arteries without major surgery, is a common and effective procedure to reestablish blood flow in the blocked arteries. In 80% of cases, a stent is placed in the vessel to keep it open following the balloon angioplasty procedure. Although the stents currently in use are excellent in providing clinical benefits, they have many serious disadvantages resulting from limited biocompatibility, leading to stent blockage and restenosis. This, in turn, leads to a decline in the quality of life of the patient, increased morbidity rate and increased health care costs. We propose to develop a more compatible coronary stent by modifying the surface of the most commonly used stainless steel stent with an irreversibly immobilized and structurally stable monolayer of the extracellular matrix protein, fibronectin (FN). By controlled engineering of physico-chemical properties of the surface, the immobilized FN will adopt the surface conformation most favorable for endothelial cell-material interactions. We hypothesize that the FN-modified stent will be more biocompatible then stents currently available on the market, which will result in a decreased restenosis rate, improved quality of life of the patient, and decreased health-care costs. We will use advanced techniques and approaches for nano-structuring of solid surfaces to engineer the stent surface at a nano/molecular level in order to achieve the desired surface bio-physico-chemical properties. We will use a wide range of experimental techniques to investigate these properties, and perform a detailed analysis of the interaction of vascular smooth muscle cells and endothelial cells with the FN-modified surface. Ultimately, we will test the effectiveness of the FN-stent in vivo using an animal model.